DVAX
Price
$9.87
Change
-$0.00 (-0.00%)
Updated
Jun 26, 01:16 PM (EDT)
Capitalization
1.62B
35 days until earnings call
ESALF
Price
$29.31
Change
-$0.00 (-0.00%)
Updated
Jun 16 closing price
Capitalization
18.29B
Interact to see
Advertisement

DVAX vs ESALF

Header iconDVAX vs ESALF Comparison
Open Charts DVAX vs ESALFBanner chart's image
Dynavax Technologies
Price$9.87
Change-$0.00 (-0.00%)
Volume$1.25K
Capitalization1.62B
Eisai
Price$29.31
Change-$0.00 (-0.00%)
Volume$1.53K
Capitalization18.29B
DVAX vs ESALF Comparison Chart in %
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. ESALF commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Buy and ESALF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (DVAX: $9.86 vs. ESALF: $29.31)
Brand notoriety: DVAX and ESALF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 60% vs. ESALF: 202%
Market capitalization -- DVAX: $1.62B vs. ESALF: $18.29B
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. ESALF’s [@Pharmaceuticals: Other] market capitalization is $18.29B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileESALF’s FA Score has 2 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • ESALF’s FA Score: 2 green, 3 red.
According to our system of comparison, ESALF is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 4 TA indicator(s) are bullish.

  • DVAX’s TA Score: 4 bullish, 3 bearish.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а -4.27% price change this week, while ESALF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.88%. For the same industry, the average monthly price growth was +13.85%, and the average quarterly price growth was +92.40%.

Reported Earning Dates

DVAX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.88% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($18.3B) has a higher market cap than DVAX($1.62B). ESALF has higher P/E ratio than DVAX: ESALF (46.30) vs DVAX (31.63). ESALF YTD gains are higher at: 14.101 vs. DVAX (-22.788). ESALF has higher annual earnings (EBITDA): 87.3B vs. DVAX (9.67M). ESALF has more cash in the bank: 268B vs. DVAX (742M). DVAX has less debt than ESALF: DVAX (257M) vs ESALF (126B). ESALF has higher revenues than DVAX: ESALF (744B) vs DVAX (232M).
DVAXESALFDVAX / ESALF
Capitalization1.62B18.3B9%
EBITDA9.67M87.3B0%
Gain YTD-22.78814.101-162%
P/E Ratio31.6346.3068%
Revenue232M744B0%
Total Cash742M268B0%
Total Debt257M126B0%
FUNDAMENTALS RATINGS
DVAX vs ESALF: Fundamental Ratings
DVAX
ESALF
OUTLOOK RATING
1..100
6335
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
7589
SMR RATING
1..100
936
PRICE GROWTH RATING
1..100
6455
P/E GROWTH RATING
1..100
9891
SEASONALITY SCORE
1..100
9565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (11) in the null industry is somewhat better than the same rating for DVAX (68) in the Biotechnology industry. This means that ESALF’s stock grew somewhat faster than DVAX’s over the last 12 months.

DVAX's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as ESALF (89) in the null industry. This means that DVAX’s stock grew similarly to ESALF’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is significantly better than the same rating for DVAX (93) in the Biotechnology industry. This means that ESALF’s stock grew significantly faster than DVAX’s over the last 12 months.

ESALF's Price Growth Rating (55) in the null industry is in the same range as DVAX (64) in the Biotechnology industry. This means that ESALF’s stock grew similarly to DVAX’s over the last 12 months.

ESALF's P/E Growth Rating (91) in the null industry is in the same range as DVAX (98) in the Biotechnology industry. This means that ESALF’s stock grew similarly to DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAX
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKSAX6.24N/A
N/A
Allspring Diversified Income Bldr A
CDDYX35.25N/A
N/A
Columbia Dividend Income Inst3
TRLUX23.66N/A
N/A
T. Rowe Price Lrg Cp Va Inv
FICDX75.84N/A
N/A
Fidelity Canada
DAEIX21.08N/A
N/A
Dean Equity Income

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-0.50%
ACET - DVAX
39%
Loosely correlated
+0.58%
SNDL - DVAX
35%
Loosely correlated
-1.61%
ESPR - DVAX
34%
Loosely correlated
-5.61%
SUPN - DVAX
34%
Loosely correlated
-1.36%
ALKS - DVAX
33%
Poorly correlated
-1.53%
More

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
N/A
ESAIY - ESALF
26%
Poorly correlated
-0.15%
DVAX - ESALF
23%
Poorly correlated
-0.50%
KHTRF - ESALF
22%
Poorly correlated
N/A
SHPH - ESALF
22%
Poorly correlated
+2.02%
BLMH - ESALF
21%
Poorly correlated
N/A
More